Abiopharma

New Form 424B2 - WELLS FARGO & COMPANY/MN <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001839882-26-039883 <b>Size:</b> 289 KB

New Form 424B2 - BARCLAYS BANK PLC <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001918704-26-023723 <b>Size:</b> 338 KB

New Form S-8 - Cellyan Biotechnology Co., Ltd <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001213900-26-089057 <b>Size:</b> 326 KB

H.B. Fuller Announces AMS Shareholders Approve Proposed Acquisition

Cerebras Powers Ultrafast Mode for OpenAI’s GPT-5.6 Sol

The Marzetti Company to Webcast Fourth Quarter and Fiscal Year 2026 Conference Call

Harris Teeter and Titan Farms Celebrate 13th Annual Peaches with a Purpose Campaign

Radoff-JEC Group Calls on Seer, Inc.’s Board of Directors to Publicly Acknowledge That the Company Needs to Be Taken Private and Disclose Timeline for Evaluating Latest Acquisition Offers

New Form SCHEDULE 13G/A - NEXTNAV INC. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0000899140-26-000824 <b>Size:</b> 10 KB

📋 Gibson Christopher (Ex-Director) plans to sell 100K shares of RECURSION PHARMACEUTICALS, INC. (at $3.31 each, total $331K) Filed: Aug 13, 2026 | ID: 005979

New Form 424B2 - UBS AG <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001839882-26-039882 <b>Size:</b> 606 KB

New Form SCHEDULE 13G/A - TaskUs, Inc. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001062993-26-004291 <b>Size:</b> 11 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001918704-26-023721 <b>Size:</b> 575 KB

New Form 424B2 - Jefferies Financial Group Inc. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001140361-26-032802 <b>Size:</b> 237 KB

New Form SCHEDULE 13G/A - Liberty Global Ltd. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0000899140-26-000822 <b>Size:</b> 10 KB